Australia markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
239.94-3.29 (-1.35%)
At close: 4:00PM EST

239.91 -0.03 (-0.01%)
Pre-market: 5:33AM EST

Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
50,238
18,662
34,288
31,176
Operating expenses
Research development
99,693
113,842
173,797
168,435
Selling general and administrative
43,177
34,417
34,409
34,451
Total operating expenses
142,870
148,259
208,206
202,886
Operating income or loss
-92,632
-129,597
-173,918
-171,710
Interest expense
12,188
12,188
12,188
14,072
Total other income/expenses net
12,986
10,515
2,782
2,013
Income before tax
-93,258
-132,694
-184,748
-183,769
Income from continuing operations
-93,258
-132,694
-184,748
-183,769
Net income
-93,258
-132,694
-184,748
-183,769
Net income available to common shareholders
-93,258
-132,694
-184,748
-183,769
Basic EPS
-
-5.51
-10.00
-12.60
Diluted EPS
-
-5.51
-10.00
-12.60
Basic average shares
-
24,100
18,488
14,633
Diluted average shares
-
24,100
18,488
14,633
EBITDA
-
-114,830
-164,401
-159,880